State Street’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-1,290,525
| Closed | -$2.62M | – | 3854 |
|
|
2016
Q1 | $2.62M | Buy |
1,290,525
+162,458
| +14% | +$290K | ﹤0.01% | 2885 |
|
|
2015
Q4 | $2.8M | Buy |
1,128,067
+23,131
| +2% | +$68.6K | ﹤0.01% | 2857 |
|
|
2015
Q3 | $2.87M | Sell |
1,104,936
-22,696
| -2% | -$59.1K | ﹤0.01% | 2829 |
|
|
2015
Q2 | $3.54M | Buy |
1,127,632
+18,777
| +2% | +$64.4K | ﹤0.01% | 2818 |
|
|
2015
Q1 | $3.17M | Buy |
1,108,855
+1,033
| +0.1% | +$2.64K | ﹤0.01% | 2817 |
|
|
2014
Q4 | $2.86M | Sell |
1,107,822
-1,211,388
| -52% | -$5.3M | ﹤0.01% | 2878 |
|
|
2014
Q3 | $17.3M | Sell |
2,319,210
-58,337
| -2% | -$545K | ﹤0.01% | 1854 |
|
|
2014
Q2 | $28M | Buy |
2,377,547
+764,785
| +47% | +$8.15M | ﹤0.01% | 1581 |
|
|
2014
Q1 | $18.7M | Sell |
1,612,762
-95,678
| -6% | -$1.13M | ﹤0.01% | 1835 |
|
|
2013
Q4 | $18.6M | Buy |
1,708,440
+161,801
| +10% | +$1.59M | ﹤0.01% | 1804 |
|
|
2013
Q3 | $16.7M | Buy |
1,546,639
+247,358
| +19% | +$2.82M | ﹤0.01% | 1812 |
|
|
2013
Q2 | $15.2M | Buy |
+1,299,281
| New | +$13M | ﹤0.01% | 1801 |
|
State Street's SZYM Position: Q2 2016 in Review
State Street sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2016, closing a stake of 1,290,525 shares — an estimated $2.62M sold.
State Street first reported a position in SZYM in Q2 2013 and held it in 12 quarters. The position peaked at $28M in Q2 2014. 0 funds tracked by Wall St. Rank hold SZYM as of Q2 2016.
- State Street reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
- State Street sold 1,290,525 SOLAZYME INC COM STK (DE) shares in Q2 2016, an estimated $2.62M.
- State Street first reported a position in SOLAZYME INC COM STK (DE) in Q2 2013 and held it in 12 quarters.
- State Street's SOLAZYME INC COM STK (DE) position peaked at $28M in Q2 2014.
- 0 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2016.
Based on State Street's 13F filing for Q2 2016, filed 12 Aug 2016.